AU2052497A - Biotin-containing compounds, biotinylation reagents and methods - Google Patents

Biotin-containing compounds, biotinylation reagents and methods

Info

Publication number
AU2052497A
AU2052497A AU20524/97A AU2052497A AU2052497A AU 2052497 A AU2052497 A AU 2052497A AU 20524/97 A AU20524/97 A AU 20524/97A AU 2052497 A AU2052497 A AU 2052497A AU 2052497 A AU2052497 A AU 2052497A
Authority
AU
Australia
Prior art keywords
biotin
methods
containing compounds
biotinylation reagents
biotinylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20524/97A
Inventor
Donald K. Hamlin
Pradip M Pathare
S. Ananda Weerawarna
Scott D. Wilbur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Original Assignee
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington filed Critical University of Washington
Publication of AU2052497A publication Critical patent/AU2052497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6893—Pre-targeting systems involving an antibody for targeting specific cells clearing therapy or enhanced clearance, i.e. using an antibody clearing agents in addition to T-A and D-M
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU20524/97A 1996-02-08 1997-02-07 Biotin-containing compounds, biotinylation reagents and methods Abandoned AU2052497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US011321 1993-01-29
US1132196P 1996-02-08 1996-02-08
PCT/US1997/002560 WO1997029114A1 (en) 1996-02-08 1997-02-07 Biotin-containing compounds, biotinylation reagents and methods

Publications (1)

Publication Number Publication Date
AU2052497A true AU2052497A (en) 1997-08-28

Family

ID=21749866

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20524/97A Abandoned AU2052497A (en) 1996-02-08 1997-02-07 Biotin-containing compounds, biotinylation reagents and methods

Country Status (2)

Country Link
AU (1) AU2052497A (en)
WO (1) WO1997029114A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846741A (en) * 1992-08-21 1998-12-08 Immunomedics, Inc. Boron neutron capture therapy using pre-targeting methods
US6228362B1 (en) 1992-08-21 2001-05-08 Immunomedics, Inc. Boron neutron capture therapy using pre-targeting methods
DE69638134D1 (en) * 1995-06-07 2010-04-08 Immunomedics Inc IMPROVED DELIVERY OF DIAGNOSTIC AND THERAPEUTIC SUBSTANCES AT ONE DESTINATION
US20010023288A1 (en) 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
AU8366398A (en) * 1998-07-07 2000-01-24 Department Of Radiation Oncology University Of Washington Trifunctional reagent for conjugation to a biomolecule
EP1196199A4 (en) * 1999-06-02 2002-06-19 Univ Washington Water soluble multi-biotin-containing compounds
ATE469661T1 (en) * 2000-06-16 2010-06-15 Mitra Medical Technology Ab METHOD FOR CONDITIONING A COLUMN WITH AVIDIN OR STREPTAVIDIN MATRIX IN A DEVICE OUTSIDE THE BODY
SE0002287D0 (en) 2000-06-16 2000-06-16 Department Of Radiation Oncolo biotin
US20020164649A1 (en) * 2000-10-25 2002-11-07 Rajendra Singh Mass tags for quantitative analysis
US20040132092A1 (en) * 2003-01-03 2004-07-08 Stetson Christopher M. Determining the density of functional moieties on polymer reagents
AU2004277403A1 (en) 2003-10-02 2005-04-14 The General Hospital Corporation Polybiotin compounds for magnetic resonance imagining and drug delivery
EP1866428A2 (en) 2005-03-18 2007-12-19 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
CZ302510B6 (en) * 2010-03-29 2011-06-22 Univerzita Palackého v Olomouci Efficient method of biotinylation of compounds containing carboxyl group using solid phase synthesis for affinity chromatography needs
CZ302669B6 (en) * 2010-03-29 2011-08-24 Univerzita Palackého v Olomouci Efficient method of biotinylation of amino compounds using solid phase synthesis for affinity chromatography needs
US20150044672A1 (en) * 2011-09-09 2015-02-12 The Trustees Of Columbia University In The City Of New York Streptavidin complexes and uses thereof
US8927732B2 (en) * 2012-03-30 2015-01-06 General Electric Company Biotin stannane for HPLC-free radioiodination
JP5924795B2 (en) 2014-06-13 2016-05-25 テンボロン オイ Complex
KR102480393B1 (en) * 2019-05-31 2022-12-23 (주)디앤디파마텍 Physiological active materials linked biotin moiety and composition for oral administration comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates

Also Published As

Publication number Publication date
WO1997029114A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
AU5551796A (en) Sample preprocessor
AU8908998A (en) Analyte detection systems
AU2245997A (en) Mutivariate sample analysis
AU9586798A (en) Analyte assaying device
AU6684496A (en) Ultra-wideband directional sampler
AU4859797A (en) Nanoparticles biosensor
AU2052497A (en) Biotin-containing compounds, biotinylation reagents and methods
AU6264398A (en) Schottky-metal detection method
AU3185199A (en) Immunoassay device and method
AU3506597A (en) Sampler
AU8548498A (en) Enhanced detection method
AU8358398A (en) Immunoassay apparatus
AU2752897A (en) Formazan-based immunoassay
AU1284899A (en) Sample retrieval system
AU3326597A (en) Immunoassay method
AU3166897A (en) Factor vii-binding reagent
AU4159697A (en) Interaction trap assay, reagents and uses thereof
AU4996796A (en) Rapid, self-performing tsh immunoassay
AUPP403098A0 (en) Method and system for selection candidates for employment
AU8133798A (en) Sorting device
AU3254799A (en) Sorting wc-accession
AU5292196A (en) Drilling device
AU7146198A (en) Method for fertility detection
AU3432597A (en) Sampler for liquids
ZA977188B (en) Immunoassay method.